Skip to main content
OpenTrials
Completed

NCT Number: NCT07017387

Impact of Education Methods on HPV Knowledge and Screening Behavior

The aim of this study is to evaluate the effect of two different health education methods (one based on motivational interviewing) on women's HPV knowledge, cervical cancer health beliefs, and screening behaviors in women aged 30-65. A total of 90 healthy women who are registered at the Incirli Family Health Center in Ankara, meet the inclusion criteria, and volunteer to participate will be randomly assigned to three groups (30 participants per group).

The control group will receive standard healthcare services. The first intervention group will receive three sessions of motivational interviewing-based health education on cervical cancer prevention through home visits, along with an informational brochure. The second intervention group will receive health education and a brochure, followed by a reminder session via phone. At the end of the study, participants in the control group will be offered the intervention of their choice.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This study aims to evaluate the effect of two different health education methods-one based on motivational interviewing-on HPV knowledge, cervical cancer health beliefs, and screening behavior in women aged 30-65. A total of 90 healthy women, registered at the Incirli Family Health Center in Ankara, who meet the inclusion criteria and provide informed consent, will be randomly assigned into three groups of 30 participants each.

The control group will receive standard healthcare services. The first intervention group will receive three face-to-face educational sessions based on motivational interviewing principles on HPV and cervical cancer prevention through home visits, along with an informational brochure. These sessions will occur during Weeks 1, 2, and 3. A final follow-up session to administer FORM II will be held in Week 8.

The second intervention group will receive a single face-to-face educational session on HPV and cervical cancer prevention (Week 1), receive a brochure, and two follow-up reminder sessions via telephone in Weeks 2 and 3. FORM II will be administered in Week 8.

After the study period, participants in the control group will be offered the opportunity to choose and receive one of the two intervention methods. All participants will complete the HPV Knowledge Scale, the Cervical Cancer and Pap Smear Test Health Belief Model Scale, and a VAS for self-assessment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between 30 and 65 years of age
  • Being literate
  • Agreeing to participate in the study
  • Being female
  • Being married
  • Having no history of cervical cancer in first-degree relatives (mother/sister)
  • Not having undergone cervical cancer screening in the last five years
  • Not having been diagnosed with cancer

Exclusion criteria

  • Being pregnant or in the postpartum period
  • Having been diagnosed with any type of cancer
  • Having a hearing or speech impairment, or a mental disorder
  • Using medication due to psychotic treatments
  • Having undergone a hysterectomy
  • Having had cervical cancer screening within the last five years
  • Having received all three doses of the HPV vaccine

Treatment and study plan

Motivational interviewing based health education

Behavioral

Participants will receive three sessions of face-to-face health education using motivational interviewing techniques through home visits, along with an informational brochure.

Health Education

Behavioral

Participants will receive one face-to-face health education session and a brochure, followed by two reminder sessions via phone.

Primary outcomes

  1. Change in screening behavior

    Time frame: 8 weeks after intervention

    Binary outcome (Yes/No) capturing whether the participant underwent screening during the follow-up period. If Yes, the result is recorded; if No, the reason for non-participation is documented.

Secondary outcomes

  1. Change in HPV Knowledge Score Measured by the 33-item HPV Knowledge Scale

    Time frame: 8 weeks after intervention

    Description: The 33-item HPV Knowledge Scale (Demir & Özdemir, 2019) assesses knowledge of HPV infection, screening, and vaccination. Each item is answered Yes/No/Don't know and scored 1 (for correct) or 0 (for incorrect/unknown). Total scores range 0-33; higher scores indicate greater knowledge.

  2. Change in Health Belief About Cervical Cancer and Pap Smear as Measured by the Cervical Cancer and Pap Smear Health Belief Model Scale (35 items)

    Time frame: 8 weeks after intervention

    The 35-item scale (Güvenç et al., 2011) has five subscales: Benefits & Motivation (8 items), Barriers (14), Perceived Severity (7), Perceived Susceptibility (3), Health Motivation (3). Responses use a 5-point Likert scale (1 = Strongly disagree to 5 = Strongly agree). Subscale scores are summed; higher scores reflect stronger beliefs, except Barriers, where higher scores indicate more perceived barriers.

  3. Change in Self-Rated Knowledge About Cervical Cancer and Screening Assessed by a 0-10 Visual Analog Scale (VAS)

    Time frame: 8 weeks after intervention

    Description: Participants rate their knowledge on a 10-cm VAS anchored at 0 ("No knowledge") and 10 ("Completely knowledgeable").

  4. Satisfaction

    Time frame: 8 weeks after intervention

    Satisfaction with standard care, health education, or MI-based health education assessed by VAS at 8 weeks

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Other

Registry information

Official study title

The Effect of Two Different Health Education Methods on Women's HPV Knowledge, Cervical Cancer Health Belief and Screening Programme.

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 12, 2025
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.